Join
Live feed
·
PRReleasevia Quantisnow
Taro Pharmaceutical Industries Ltd. logo

Galderma Delivers Strong H1 2022 Results and Continued Innovation Across Its Leading Dermatology Portfolio

ByQuantisnow·Wall Street's wire, on your screen.
TARO· Taro Pharmaceutical Industries Ltd.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TARO (Taro Pharmaceutical Industries Ltd.) and more on Quantisnow.